Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
about
Angiotensin-converting enzyme inhibitors for congestive heart failure in childrenAngiotensin-converting enzyme inhibitors for congestive heart failure in childrenCongestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiencyEfficacy and dosage of enalapril in congenital and acquired heart disease.Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind studyImpact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure TrialAngiotensin converting enzyme inhibitors in heart failure: how good are they?Role of ACE inhibitors in uncomplicated essential hypertension.ACE inhibitors for heart failure: a question of doseNeurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.Cough associated with captopril and enalaprilFactors influencing survival and mode of death in severe chronic ischaemic cardiac failure.Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effectsMortality in heart failure: clinical variables of prognostic valueLong-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failureWhich vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.Enalapril in African patients with congestive cardiac failure.Race and association of angiotensin converting enzyme/angiotensin receptor blocker exposure with outcome in heart failure.Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction.Angiotensin converting enzyme inhibitors for hypertension and heart failure?Vascular tone in heart failure: the neuroendocrine-therapeutic interfacePeripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.Left ventricular dysfunction and ventricular arrhythmias: reducing the risk of sudden death.Diagnosis and management of heart failure.Cough and angiotensin converting enzyme inhibition.Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.Antihypertensive and organ-protective effects of benazepril.The Three-Decade Long Journey in Heart Failure Drug Development.Therapeutic progress--review XXXIV. Congestive cardiac failure.The positive association of cough with angiotensin-converting enzyme inhibitors.Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.The renin-angiotensin-aldosterone-system and right heart failure in congenital heart disease.Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.Enalapril: a long-acting angiotensin-converting enzyme inhibitor.The clinical use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
P2860
Q24188260-94A96882-98FB-456E-822B-41F9F37A3DAAQ24202598-F9FF0D51-1948-403F-B3E5-4ED44F72AC71Q28328514-AB7142E6-9B60-4E3E-9564-4BB9455E251AQ28369543-72FB3533-FAF0-4FF9-B14A-78B6B89042BAQ28378632-84625120-5D6E-4291-B974-CE042C4576EEQ31863980-AFD91741-E01F-406D-B319-D70816F5CED3Q33611333-16714AD6-D360-440D-89C9-945641FCD2CCQ33611888-11237178-E266-45E2-85E9-B07F29759695Q33612739-8F4B83C1-70D9-485E-A857-F26104C3E2BBQ33614270-5F33D566-46D6-4164-A301-740D020492C6Q33614305-38AE88D9-720E-4892-8D18-4F7E626BA110Q33614319-31ABBEF4-CDAB-4CF8-A633-EEF15FBBC0DEQ33789930-3586E3E5-E083-4529-8479-8FC7A3B1A494Q34070598-171D9F3D-4E3C-4C5D-8FFE-8BA9DE37B25EQ34117868-8839E211-03DC-43C5-B280-7146AB96F189Q34118531-468F9A5F-D690-4950-8D88-B6242E8041CCQ34118615-E633F681-202F-4949-B354-0F02C9892240Q34210098-06D8CE14-F6C0-4ADC-8234-0FCBA4C0604BQ34358032-C087C475-CA41-46B5-8D2F-62D001D7F0A8Q34358252-61E9A144-36F1-4FEC-8EE3-7BF24C9478E3Q34397493-337752E7-0A0F-478E-A7E5-50345D2C6F4CQ35088348-28452205-E73A-4184-8982-9554A429DA01Q35888473-19F8DF39-7F2D-4E0F-97BD-6A94C2256102Q35958231-733B4514-DA0E-4FB6-B396-DC17E21FDE04Q35990307-5878AA57-2409-483F-9559-6B22162114C4Q36808117-DED40D38-EFE6-4934-8F5C-85B3F48D9F4AQ36818647-1259D084-D982-4C07-9BF7-51D8908D4234Q36832235-F7A7E039-6C14-472B-9171-4078D6FF67F8Q36883992-1A841052-BF5F-4420-B93F-EE5312BC3E24Q36896077-7B9C838E-7E0B-4B6C-B71E-943E148D3AADQ37170615-5DFF415C-98B2-44E0-9911-092BBBB0610AQ37812376-E2BEF340-5D14-4E37-B5E5-811F2F07BB4BQ38558614-0930B490-67D3-4E72-8CD2-FBC13B8B63CAQ38606288-BB3E1600-B1C4-4B41-BC88-A86204DCA682Q38635844-468CEF11-3328-486E-8B2F-452DE7B2E296Q38747861-74B37122-6E12-47E8-ABFE-88066EEE76A3Q38888906-26929CE6-F5B4-4CCF-A2C6-E74F05559C6DQ38965377-8357E450-5920-4EEC-95E7-23FD331B548BQ39177686-D109B733-BEEB-48A3-A37B-634E285B479EQ39510450-691945F5-E14E-4B8B-A30F-AFF82A8D7E18
P2860
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Effects of enalapril in heart ...... hormones, and metabolic state.
@ast
Effects of enalapril in heart ...... hormones, and metabolic state.
@en
type
label
Effects of enalapril in heart ...... hormones, and metabolic state.
@ast
Effects of enalapril in heart ...... hormones, and metabolic state.
@en
prefLabel
Effects of enalapril in heart ...... hormones, and metabolic state.
@ast
Effects of enalapril in heart ...... hormones, and metabolic state.
@en
P2093
P2860
P356
P1476
Effects of enalapril in heart ...... hormones, and metabolic state.
@en
P2093
Cleland JG
Hodsman GP
Robertson I
Robertson JI
P2860
P304
P356
10.1136/HRT.54.3.305
P577
1985-09-01T00:00:00Z